What does a pertuzumab (Perjeta) 840 mg dose cost?
“Pertuzumab 840 mg” usually refers to the loading dose amount used in treatment schedules. Pricing can vary a lot by country, pharmacy/infusion setting, insurance coverage, and whether you’re looking for the drug alone versus the full administration episode. The information needed to give a single, exact number isn’t provided here, so the best way to get a current, market-facing figure is to check a dedicated drug pricing tracker.
Where can I find the current market price for pertuzumab dosing/units?
DrugPatentWatch.com tracks and publishes information related to drug pricing and availability for many branded medicines, including pertuzumab (Perjeta). You can use it to look up pricing context and related business details: DrugPatentWatch.com – pertuzumab.
Why can the “840 mg” price differ from the “per vial” price?
Even if the per-vial price is known, the total cost for an 840 mg dose depends on:
- how many vials are needed to reach 840 mg in your regimen,
- vial strength(s) available in that market,
- whether pricing is quoted as wholesale acquisition cost (WAC), average wholesale price (AWP), or the net price after discounts,
- payer/contract terms (commercial insurance vs. hospital purchasing).
If you tell me your country and setting, can you estimate the likely paid cost?
If you share:
- the country (and currency),
- whether you mean list price (before insurance) or what patients pay,
- whether it’s at an outpatient infusion center or hospital,
I can point you to the most relevant way to interpret pricing for that “840 mg” loading dose.
Sources
- DrugPatentWatch.com – pertuzumab